Cephalon News

The Dow Jones industrial average was down an alarming 5 percent Monday morning despite Friday's passage of the bank bailout.

Main Category: Pharma Industry / Biotech Industry Also Included In: Health Insurance / Medical Insurance Cephalon on Monday completed a $443.9 million settlement with federal and state regulators related to ...

Amgen wins patent case against Roche - The courts have decided that Roche cana TMt sell its anemia drug Mircera in the United States, since it violates patent law by competing with Amgen a TMs anemia offerings, ...

The Vermont Attorney General's office says the state's Medicaid program will receive almost $1.1 million to settle charges the pharmaceutical company Cephalon, Inc., improperly marketed certain drugs.

SDDrug Settlement,0101 South Dakota gets $49,000 in drug settlement Eds: APNewsNow.

Apparently, not very much, considering their off-label promotions of opiate-laced lollipops.

Aloha Petroleum Ltd. , a privately held oil marketer, has selected CBX , a consultancy agency based in New York, to design a prototypical convenience store, beginning with a new, ground-up unit to open on Oahu ...

Cephalon, Inc. announced today it has finalized a previously announced agreement in principle with the U.S. Attorney's Office for the Eastern District of Pennsylvania, the U.S. Department of Justice and various ...

The U.S. Environmental Protection Agency has levied a $65,050 fine against Vector Tobacco Inc.

Mon, Sep 29, 2008 Nevada Attorney General Catherine Cortez Masto announced today that the state had reached a tentative $6.9 million agreement with a major drug manufacturer.

Drug maker Cephalon, completing a previously announced settlement, will pay $425 million for illegally marketing a highly addictive lollipop painkiller and two other drugs for non-approved uses.

Bangalore-based Biocon Ltd has been ranked as the 7th largest employer amongst the top global biotechnology companies, behind Biogen but ahead of global life science companies Gilead , Cephalon and Amylin.

The FDA delivered to Cephalon a letter yesterday saying it would not approve expanded indications for its pain drug Fentora until the company gave it more information on how it would prevent the drug from being ...

Mark S. Purcell joined Nason Construction as business development manager and project executive.

As fundamentals-focused long-term investors, Fools never base an investment decision on the daily gyrations of the market.

For drug developers, few events can affect their share price more than an FDA decision about one of their drug candidates.

Cephalon, Inc. Ending Provigil Promotion Deal with Takeda Pharmaceutical Co. Ltd. 9/5/2008 Cephalon Inc.

Cephalon Inc. of East Whiteland will end its co-promotion agreement with Takeda Pharmaceuticals North America Inc.

Cephalon Inc. has provided written notice to Takeda Pharmaceuticals North America Inc.

Beijing SL Pharmaceutical Co. Ltd. received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin clinical trials of drug for male infertility.